Haemonetics (HAE) Research & Development (2009 - 2026)
Haemonetics (HAE) posted quarterly Research & Development of $14.4 million for Q1 2026, down 21.08% year-over-year from $18.3 million in Q1 2025, and up 1.83% quarter-over-quarter from $14.2 million in Q4 2025.
Haemonetics (HAE) Research & Development (2009 - 2026) Analysis & Trends
Haemonetics' Research & Development history runs 18 years deep, the most recent figure standing at $14.4 million for Q1 2026.
- In Q1 2026, Research & Development fell 21.08% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $59.8 million (down 4.71% YoY), while the FY2026 annual figure was $59.8 million, down 4.71% from the prior year.
- Research & Development for Q1 2026 stood at $14.4 million, up from $14.2 million in the prior quarter.
- The five-year high for Research & Development was $18.3 million in Q1 2025, with the low at $10.0 million in Q1 2022.
- The 5-year median for Research & Development is $14.2 million (2024), against an average of $13.9 million.
- The sharpest annual moves came in 2022 and 2026: Research & Development jumped 33.81% in 2022, then dropped 21.08% in 2026.
- Haemonetics' Research & Development stood at $12.7 million in 2022, then grew by 4.54% to $13.3 million in 2023, then increased by 19.33% to $15.8 million in 2024, then slipped by 10.37% to $14.2 million in 2025, then gained by 1.83% to $14.4 million in 2026.
- Business Quant data shows HAE's Research & Development at $14.4 million in Q1 2026, $14.2 million in Q4 2025, and $14.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn | -1.02 Bn |
| 10 | Haemonetics | 4.77 Bn | 4.55 Bn | 202.80 Mn | 16.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 16.20 Mn |
| Mar 28, 2026 | 14.45 Mn |
| Dec 27, 2025 | 14.19 Mn |
| Sep 27, 2025 | 14.87 Mn |
| Jun 28, 2025 | 16.26 Mn |
| Mar 29, 2025 | 18.31 Mn |
| Dec 28, 2024 | 15.83 Mn |
| Sep 28, 2024 | 14.14 Mn |
| Jun 29, 2024 | 14.45 Mn |
| Mar 30, 2024 | 15.86 Mn |
| Dec 30, 2023 | 13.27 Mn |
| Sep 30, 2023 | 12.67 Mn |
| Jul 1, 2023 | 12.65 Mn |
| Apr 1, 2023 | 15.64 Mn |
| Dec 31, 2022 | 12.69 Mn |
| Oct 1, 2022 | 10.90 Mn |
| Jul 2, 2022 | 10.90 Mn |
| Apr 2, 2022 | 13.21 Mn |
| Jan 1, 2022 | 10.04 Mn |
| Oct 2, 2021 | 10.85 Mn |